Literature DB >> 17181449

Uses and complications of mitomycin C in ophthalmology.

Ali A Mearza1, Ioannis M Aslanides.   

Abstract

Mitomycin C is a chemotherapeutic agent that acts by inhibiting DNA synthesis. Its use and application in ophthalmology has been increasing in recent years because of its modulatory effects on wound healing. Current applications include pterygium surgery, glaucoma surgery, corneal refractive surgery, cicatricial eye disease, conjunctival neoplasia and allergic eye disease. Although it has been used successfully in these conditions, it has also been associated with significant complications. This article reviews the current trends and uses of mitomycin C in the eye and its reported complications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17181449     DOI: 10.1517/14740338.6.1.27

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  20 in total

1.  Use of adjunctive mitomycin C in external dacryocystorhinostomy surgery compared with surgery alone in patients with nasolacrimal duct obstruction: A prospective, double-masked, randomized, controlled trial.

Authors:  Seyhmus Ari; Ramazan Gun; Serdar Surmeli; Ahmet Engin Atay; Ihsan Caca
Journal:  Curr Ther Res Clin Exp       Date:  2009-08

2.  5-Fluorouracil versus mitomycin C as adjuncts to conjunctival autograft in preventing pterygium recurrence.

Authors:  Charles O Bekibele; Adeyinka Ashaye; Bolutife Olusanya; Aderonke Baiyeroju; Oluyemi Fasina; Adekunmi O Ibrahim; Olufunmi Ogun
Journal:  Int Ophthalmol       Date:  2012-01-15       Impact factor: 2.031

3.  Primary and Secondary Optic Nerve Sheath Meningioma.

Authors:  Elena Solli; Roger E Turbin
Journal:  J Neurol Surg B Skull Base       Date:  2021-02-18

4.  Corneal fibrosis abrogation by a localized AAV-mediated inhibitor of differentiation 3 (Id3) gene therapy in rabbit eyes in vivo.

Authors:  Suneel Gupta; Michael K Fink; Duraisamy Kempuraj; Nishant R Sinha; Lynn M Martin; Landon M Keele; Prashant R Sinha; Elizabeth A Giuliano; Nathan P Hesemann; Sudhanshu P Raikwar; Shyam S Chaurasia; Rajiv R Mohan
Journal:  Mol Ther       Date:  2022-07-02       Impact factor: 12.910

5.  Antiproliferative property of hexadecyloxypropyl 9-[2-(phosphonomethoxy) ethyl] guanine (HDP-PMEG) for unwanted ocular proliferation.

Authors:  Jiangping Hou; Yuli Li; Zhonglou Zhou; Nadejda Valiaeva; James R Beadle; Karl Hostetler; William R Freeman; Dan-Ning Hu; Hao Chen; Lingyun Cheng
Journal:  Mol Vis       Date:  2011-03-02       Impact factor: 2.367

6.  Target drug delivery system as a new scarring modulation after glaucoma filtration surgery.

Authors:  Tingting Shao; Xiaoning Li; Jian Ge
Journal:  Diagn Pathol       Date:  2011-07-08       Impact factor: 2.644

7.  Paclitaxel inhibits growth, migration and collagen production of human Tenon's fibroblasts--potential use in drug-eluting glaucoma drainage devices.

Authors:  Lars Choritz; Jochen Grub; Maria Wegner; Norbert Pfeiffer; Hagen Thieme
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-11-07       Impact factor: 3.117

8.  Potential risk of mitomycin C at high concentrations on peripheral nerve structure.

Authors:  Tao Sui; Jinhong Zhang; Shihao Du; Changhui Su; Jun Que; Xiaojian Cao
Journal:  Neural Regen Res       Date:  2014-04-15       Impact factor: 5.135

Review 9.  Surgery on the Trabecular Meshwork: Histopathological Evidence.

Authors:  Shibal Bhartiya; Parul Ichhpujani; Tarek Shaarawy
Journal:  J Curr Glaucoma Pract       Date:  2015-09-25

10.  Scleral resection in chronic central serous chorioretinopathy complicated by exudative retinal detachment.

Authors:  Pradeep Venkatesh; Rohan Chawla; Koushik Tripathy; Harsh Inder Singh; Ravi Bypareddy
Journal:  Eye Vis (Lond)       Date:  2016-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.